<DOC>
	<DOCNO>NCT01359852</DOCNO>
	<brief_summary>The purpose study evaluate [ 11C ] JNJ-42491293 PET ligand healthy adult volunteer .</brief_summary>
	<brief_title>A Study 11CJNJ-42491293 , Possible PET Ligand mGlu2 Receptor , Healthy Adult Volunteers</brief_title>
	<detailed_description>This open-label ( volunteer know identity assign treatment ) study healthy adult volunteer consist 4 consecutive part , A , B , C , D. Advancement part B , C , D occur objective precede part meet . Healthy adult volunteer recruit part study . This first study 42491293 give healthy adult volunteer . Part A investigate measurement radiation ( refer radiation dosimetry ) 42491293 . Part B measure regional brain kinetics ( activity ) binding property 42491293 . Part C ass dose dependent block 42491293 40411813 brain tissue follow single oral dos 40411813 . Part D ass 'duration occupancy ' metabotropic glutamate receptor-2 ( mGluR2 ) positive allosteric modulator ( PAM ) site brain 40411813 compare peripheral clearance . In study , 42491293 radio-labeled evaluate potential positron emission tomography ( PET ) ligand use image study brain detect bind 40411813 , compound develop treat patient psychiatric condition schizophrenia anxiety disorder . In Parts A , B , C , D , [ 11C ] JNJ-42491293 ( 300 370 MBq ) dose i.v . bolus injection . During Part C D , JNJ-40411813 ( 500mg ) administer orally ( mouth ) 1.5 3 hour prior schedule PET scan .</detailed_description>
	<criteria>Body mass index ( BMI ) 18 30 kg/m2 , inclusive ( BMI = weight/height2 ) Nonsmokers ( least 3 month screen ) Healthy basis result physical examination , vital sign , 12lead ECG , clinical laboratory test perform screen determine Investigator ( study physician ) Willing adhere prohibition restriction specify protocol Healthy volunteer must sign informed consent document indicate understand purpose procedure require study willing participate study History current medical illness Investigator consider clinically significant History current psychiatric neurological illness include claustrophobia ( abnormal fear narrow enclose space ) Exposed &gt; 1 mSv ionize radiation participate volunteer research study year start study Any clinically significant Magnetic Resonance Imaging ( MRI ) abnormalities screen , determined neuroradiologist , relevant study ( applicable part A ) Metal implant ( pacemaker , joint replacement , etc . ) metal splinter heavy tattoo , relevant MRI ( applicable Part A ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>JNJ-42491293</keyword>
	<keyword>JNJ-40411813</keyword>
	<keyword>Metabotropic glutamate subtype 2 receptor ( mGlu2R )</keyword>
	<keyword>Positive allosteric modulator ( PAM )</keyword>
	<keyword>positron emission tomography ( PET )</keyword>
</DOC>